JD Health International Inc. (for the month ended 30 June 2026) reported stable authorised capital alongside marginal issuance and sizable pending cancellations.

Authorised Capital • Remained at 100.00 billion ordinary shares with a par value of USD 0.0000005, equivalent to USD 50,000 in authorised capital.

Issued Share Movement • Outstanding shares rose by 0.30 million to 3.21 billion following the allotment of shares on 4 June 2026 under the Post-IPO Share Award Scheme. • No treasury shares were transferred or cancelled during the month.

Equity Incentive Schemes • Pre-IPO ESOP: 9.43 million options outstanding; no exercises, grants, lapses or cancellations in June. • Post-IPO Share Option Scheme: no options outstanding; remaining mandate allows up to 312.71 million shares to be granted. • Post-IPO Share Award Scheme: 15.04 million shares remain available after the June issuance.

Share Repurchases Pending Cancellation • A cumulative 21.54 million shares repurchased between 15 May 2026 and 30 June 2026 have not yet been cancelled, comprising 20.94 million shares (transaction dated 20 June 2025) and 0.60 million shares (29 June 2026).

Public Float • The company confirmed compliance with the Main Board’s minimum 25 % public-float threshold as at 30 June 2026.

Funds Raised • No cash proceeds were generated in June from option exercises or other equity issuances.

Overall, JD Health’s capital structure saw a negligible 0.01 % increase in issued shares during June, while the sizeable pool of repurchased shares pending cancellation suggests a forthcoming reduction in outstanding share count once cancellations are executed.